Skip to main content
. 2025 Apr 30;16:1535352. doi: 10.3389/fphar.2025.1535352

FIGURE 5.

FIGURE 5

Targeted amino acid metabolomics analysis of clinical patient serum and non-targeted metabolomics analysis of mouse serum. (A) PLS-DA analysis of clinical non-targeted metabolomics (n = 50); (B) Permutation analysis of clinical non-targeted metabolomics; (C) heatmap analysis of clinical non-targeted metabolomics; (D) pathway enrichment analysis of clinical non-targeted metabolomics; (E) Receiver operating characteristic curve of 5-HTP in serum of clinical patients; (F) The level of 5-HTP in serum of clinical patients, (G) PLS-DA analysis of targeted metabolomics in mice (n = 3); (H) Permutation analysis of targeted metabolomics in mice; (I) L-tryptophan content in mouse serum; (J) Heatmap analysis of targeted metabolomics in mice.